Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...

Wellness influencer Janelle Rohner is receiving backlash after admitting to, and then apologizing for, using a weight loss ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit alcohol and drugs ...

Defensive lineman Desmond Watson shed 26 pounds in less than a month, but if selected in the NFL draft would still be ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

In this video at Obesity Medicine 2025, Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC, FNLA, discusses highlights from his talk ...